Oruka Therapeutics (ORKA) Shares Outstanding (2010 - 2026)

Oruka Therapeutics' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $392504.0 for Q4 2020.

• On a quarterly basis, Shares Outstanding (Entity) rose 256.5% year-over-year to $392504.0 in Q4 2020; TTM through Dec 2020 was $392504.0, a 256.5% increase from a year earlier, with the FY2020 full-year figure at $392504.0, up 256.5% from the prior year.
• Shares Outstanding (Entity) declined to $392504.0 in Q4 2020 per ORKA's latest filing, from $503673.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $503673.0 in Q3 2020 and bottomed at $41931.0 in Q1 2016.
• The 5-year median for Shares Outstanding (Entity) is $64465.0 (2018), against an average of $112071.2.
• Across the five-year window, Shares Outstanding (Entity) grew 0.34% in 2016 and surged 279.17% in 2020, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $42050.0 in 2016, then advanced by 29.65% to $54516.0 in 2017, then climbed by 18.25% to $64466.0 in 2018, then surged by 70.78% to $110098.0 in 2019, then soared by 256.5% to $392504.0 in 2020.
• Per Business Quant, the three latest ORKA Shares Outstanding (Entity) figures stand at $392504.0 (Q4 2020), $503673.0 (Q3 2020), and $149486.0 (Q2 2020).